Literature DB >> 3654938

Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity.

G A Linde1, M Granström, C Orvell.   

Abstract

Total immunoglobulin G (IgG) and IgG subclass reactivities with purified mumps glycoproteins (GP) and nucleoprotein (NP), measured in enzyme-linked immunosorbent assays (ELISAs), were compared with titers in a mumps microneutralization assay (NT). For determination of mumps immunity, the sensitivity of both ELISAs was 100% in comparison with the NT and the specificity was 90%. IgG1 was the dominant subclass against the two antigens found in seropositive healthy individuals. In samples from patients with clinical mumps infections and positive mumps IgM, titer rises of total IgG against NP were invariably seen before GP titer rises. Significant but often late titers rises in NT were found in all patients. Changes of IgG1 levels against both antigens followed the changes of total specific IgG. High levels of IgG3 against NP were diagnostic for mumps infection. In parainfluenza infections, titer rises in the mumps ELISAs and NT were found, but mumps IgM, NP IgG3, and the high ratio between the NP and GP titers found in early samples from patients with mumps infection were not observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654938      PMCID: PMC269301          DOI: 10.1128/jcm.25.9.1653-1658.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Serologic responses to para-influenza viruses in patients with mumps virus injection.

Authors:  E H LENNETTE; F W JENSEN; R W GUENTHER; R L MAGOFFIN
Journal:  J Lab Clin Med       Date:  1963-05

2.  Comparison of neutralization and hemagglutination-inhibition techniques for measuring mumps antibody.

Authors:  E B Buynak; J E Whitman; R R Roehm; D H Morton; G P Lampson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

3.  Structural polypeptides of mumps virus.

Authors:  C Orvell
Journal:  J Gen Virol       Date:  1978-12       Impact factor: 3.891

4.  The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren.

Authors:  B Christenson; L Heller; M Böttiger
Journal:  J Biol Stand       Date:  1983-10

5.  Hemolysis-in-gel and neutralization tests for determination of antibodies to mumps virus.

Authors:  L Grillner; J Blomberg
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

6.  Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity.

Authors:  J Lowe; P Bird; D Hardie; R Jefferis; N R Ling
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

7.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Enzyme-linked immunosorbent assay (ELISA) for mumps virus antibodies.

Authors:  T Popow-Kraupp
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  The enzyme-linked immunosorbent assay (ELISA) for determination of IgG and IgM antibodies after infection with mumps virus.

Authors:  M E Nicolai-Scholten; R Ziegelmaier; F Behrens; W Höpken
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

10.  Mumps-specific immunoglobulin M and G antibodies in natural mumps infection as measured by enzyme-linked immunosorbent assay.

Authors:  P Ukkonen; M L Granström; K Penttinen
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

View more
  12 in total

1.  Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3.

Authors:  A Linde; R Söderström; C I Smith; M Sällberg; H Dahl; R Grubb; J Björkander; L Hammarström
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

3.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

4.  Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals.

Authors:  H J Windle; Y S Ang; V Athie-Morales; V A Morales; R McManus; D Kelleher
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

5.  Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.

Authors:  T Mathiesen; P A Broliden; J Rosen; B Wahren
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

6.  Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

Authors:  Jeremy Mauldin; Kathryn Carbone; Henry Hsu; Robert Yolken; Steven Rubin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.

Authors:  G Edevåg; B Wahren; A D Osterhaus; V A Sundqvist; M Granström
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells.

Authors:  S K Samal; M K Pastey; T McPhillips; D K Carmel; S B Mohanty
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

9.  Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.

Authors:  Stéphanie Ravault; Damien Friel; Emmanuel Di Paolo; Adrian Caplanusi; Paul Gillard; Michael Povey; Stephane Carryn
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

10.  Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus.

Authors:  A Ndifuna; A K Waters; M Zhou; E W Collisson
Journal:  J Virol Methods       Date:  1998-01       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.